Brainaurora-b (6681.HK)
6681.HK Stock Price Chart
Explore Brainaurora-b interactive price chart. Choose custom timeframes to analyze 6681.HK price movements and trends.
6681.HK Company Profile
Discover essential business fundamentals and corporate details for Brainaurora-b (6681.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
8 Jan 2025
Employees
159.00
Website
https://66nao.cnCEO
Xiaoyi Wang
Description
BrainAurora Medical Technology Limited develops medical-grade digital therapy (DTx) products for cognitive impairment. The company offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies. It develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Cognitive Ability Testing software; the Cognitive Ability Supplemental Screening and Assessment software; and the Dyslexia Supplemental Screening and Assessment software. The company was founded in 2012 and is based in Shaoxing, China.
6681.HK Financial Timeline
Browse a chronological timeline of Brainaurora-b corporate events including earnings releases, dividend announcements, and stock splits.
6681.HK Stock Performance
Access detailed 6681.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.